From: Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections
 | No VAD (n = 84) | VAD (n = 35) |
---|---|---|
Patients with ≥1 post transplant bacterial/candida infection episode, n (%) | 39 (46.4) | 12 (34.3) |
Number of episodes of bacterial/candida infections per patient; mean (SD) | 0.83 (1.31) | 0.51 (0.82) |
Number of post-transplant bacterial/candida infections episodes | 70 | 18 |
Sites of bacterial/candida infections; n (%)a | Â | Â |
 - Respiratory tract  - Bacteremia  - Urinary tract  - Surgical site  - Otherb | 18 (25.7) 11 (15.7) 12 (17.1) 17 (24.3) 17 (24.3) | 4 (22.2) 5 (27.7) 3 (16.7) 7 (38.9) 2 (11.1) |
Microorganisms; n (%) | Â | Â |
 - Escherichia coli  - Coagulase Negative Staphylococci  - Staphylococcus aureus  - Pseudomonas sp.  - Clostridium difficile  - Enterobacter sp.  - Candida sp.  - Polymicrobial  - Other | 10 (14.3) 6 (8.6) 6 (8.6) 6 (8.6) 5 (7.1) 6 (8.6) 6 (8.6) 5 (7.1) 19 (27.1) | 2 (11.1) 1 (5.6) 1 (5.6) 0 2 (11.1) 2 (11.1) 1 (5.6) 3 (16.7) 7 (38.9) |
Viral infections | Â | Â |
 - CMV infection  - VZV infection  - HSV infection | 31 (36.9) 8 (9.5) 15 (17.9) | 8 (22.9) 3 (8.6) 1 (2.9) |
Other fungal infections | Â | Â |
 - Aspergillus spp.infection  - Pneumocystis jiroveci pneumonia | 7 (8.3) 3 (3.6) | 1 (2.9) 0 (0.0) |
Length of stay after transplant, days; mean (SD) | 60.8 (65.0) | 82.9 (127.6) |
Patients with treated acute rejection, n (%) | 57 (67.9) | 22 (62.9) |
Survival; n (%) | 69 (82.1) | 29 (82.9) |